Financials data is unavailable for this security.
View more
Year on year Charles River Laboratories International Inc had little change in net income (from 486.23m to 474.62m) despite revenues that grew 3.86% from 3.98bn to 4.13bn.
Gross margin | 35.93% |
---|---|
Net profit margin | 10.54% |
Operating margin | 13.00% |
Return on assets | 5.48% |
---|---|
Return on equity | 11.66% |
Return on investment | 6.33% |
More ▼
Cash flow in USDView more
In 2023, Charles River Laboratories International Inc increased its cash reserves by 17.94%, or 43.27m. The company earned 683.90m from its operations for a Cash Flow Margin of 16.56%. In addition the company used 563.16m on investing activities and also paid 85.52m in financing cash flows.
Cash flow per share | 14.87 |
---|---|
Price/Cash flow per share | 14.34 |
Book value per share | 73.97 |
---|---|
Tangible book value per share | -2.36 |
More ▼
Balance sheet in USDView more
Current ratio | 1.48 |
---|---|
Quick ratio | 1.14 |
Total debt/total equity | 0.616 |
---|---|
Total debt/total capital | 0.3784 |
More ▼
Growth rates in USD
SmartText is unavailable
EPS growth(5 years) | 15.57 |
---|---|
EPS (TTM) vs TTM 1 year ago | -13.24 |